Mobia Medical Acquisition | Healthcare Deal in CA

Mobia Medical has completed the acquisition of Mobia Medical, a medical devices business in California, for $150 million. Mobia Medical develops a vagus nerve stimulation neurostimulation device for stroke rehabilitation, targeting improved upper limb and arm function in chronic ischemic stroke survivors. The company’s Vivistim system is implanted and paired with therapy exercises to support hand and arm recovery, with FDA approval in 2021 and marketing beginning in 2023. As an other acquisition within healthcare deals CA, the medical devices acquisition supports broader access and awareness through expanded territory management and education for stroke centers, primary care physicians, medical societies, and payers.